Jordan Holt

Jordan Holt has a diverse work experience in the field of medical research and writing. They began their career in 2014 as a Year in Research Student at The Institute of Cancer Research, working in the Dynamical Cell Systems team. During this time, they gained experience in high throughput RNAi screening, molecular biology, and image analysis.

After completing their undergraduate studies, Jordan continued their research journey, joining Imperial College London in 2020 as a Postdoctoral Researcher. They worked in the cell cycle control lab headed by Dr. Alexis Barr at the MRC-LMS. Their project involved a collaboration with AstraZeneca, focusing on identifying novel markers of tumor dormancy in breast cancer through a high-throughput screen. Jordan stayed in this role until 2022.

In 2023, Jordan took on a new position as a Postdoctoral Researcher at Imperial College London. However, their tenure in this role was relatively short, ending in July 2023.

Currently, Jordan is working as an Associate Medical Writer at Prime Global, starting in July 2023. This role showcases their skills in medical writing and indicates a transition into a new area of expertise.

Overall, Jordan Holt's work experience demonstrates their commitment to medical research and their ability to adapt to different roles within the field.

Jordan Holt completed their high school education at The King's School in Macclesfield from 2005 to 2012. They then pursued a Bachelor's Degree in Biochemistry at Imperial College London, graduating in 2016. Subsequently, Jordan enrolled at The Institute of Cancer Research and obtained a Doctor of Philosophy (Ph.D.) degree in Biochemistry in 2020.